Forest Escapes Lexapro Marketing Class Action

Law360, Los Angeles (March 5, 2014, 6:08 PM EST) -- A Massachusetts federal judge on Wednesday tossed a putative class action brought against Forest Laboratories Inc. by California purchasers of the antidepressant Lexapro who said Forest misrepresented information on the drug’s efficacy for adolescents, holding that the claims are barred by California’s safe harbor provision.

The lawsuit, which was filed in February 2013 and arose out of the marketing and sales of the depression drug by Forest, was added as a tag-along to a larger multidistrict case accusing Forest of fraudulently marketing Celexa and Lexapro as...
To view the full article, register now.